688580 伟思医疗
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)6.2196.2678.6376.12912.100
总资产报酬率 ROA (%)5.6075.6247.8085.64711.186
投入资产回报率 ROIC (%)6.0946.1418.4445.98411.716

边际利润分析
销售毛利率 (%)66.86165.44867.72972.47874.781
营业利润率 (%)34.59327.87232.11532.47845.270
息税前利润/营业总收入 (%)33.95226.20528.56427.03142.044
净利润/营业总收入 (%)31.37925.48929.47929.17341.283

收益指标分析
经营活动净收益/利润总额(%)79.45466.39676.78370.47077.581
价值变动净收益/利润总额(%)8.65012.1446.41015.12710.414
营业外收支净额/利润总额(%)0.2331.5671.0461.3071.369

偿债能力分析
流动比率 (X)6.8186.0728.27310.20713.810
速动比率 (X)6.5435.8708.0109.93813.516
资产负债率 (%)9.06010.5979.9269.2436.449
带息债务/全部投入资本 (%)1.9311.9730.3060.8342.099
股东权益/带息债务 (%)5,078.6624,965.53232,005.58211,681.9854,659.029
股东权益/负债合计 (%)1,003.811843.674907.439981.9201,450.667
利息保障倍数 (X)-47.023-12.414-7.343-4.599-10.909

营运能力分析
应收账款周转天数 (天)20.00427.79422.48125.41815.573
存货周转天数 (天)105.280102.42590.206132.738112.110